Pressurized intraperitoneal aerosol chemotherapy: a review of the introduction of a new surgical technology using the IDEAL framework. Issue 2 (19th January 2020)

• Record Type: Journal Article
• Authors: Tate, S J; Torkington, J
• Is Part Of: BJS open. Volume 4:Issue 2(2020)
• Page Start: 206
• Page End: 215
• Publication Date: 2020-01-19
• Subjects: Surgery -- Periodicals; 617.005
• DOI: 10.1002/bjs5.50257
• Languages: English
• ISSNs: 2474-9842

Abstract

Abstract: Background: The IDEAL (Idea, Development, Evaluation, Assessment, Long-term study) framework is a scheme of investigation for innovative surgical therapeutic interventions. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a procedure based on laparoscopy to deliver intraperitoneal chemotherapy for peritoneal metastases, introduced in 2011. The aim of this article was to review literature on PIPAC and assess whether development of the technique has followed the IDEAL framework. Methods: A search of MEDLINE and Embase was carried out to identify scientific reports on PIPAC published between January 2000 and February 2019. The studies were categorized according to the IDEAL stages. Results: Eighty-six original research papers on PIPAC were identified. There were 23 stage 0, 18 stage 1, 25 stage 2a and six stage 2b studies. Protocol papers for stage 1, 2b and 3 studies, and trial registrations for stage 2a studies, were also identified. The number of centres publishing reports and the number of publications has increased each year. Overall, there has been progression through the IDEAL stages; however, about 60 per cent of clinical reports published in 2018 were stage 1 Idea-type studies. Conclusion: Since its introduction, studies investigating PIPAC have progressed in line with the IDEAL framework. However, the majority of studies reported recently were stage 0 and 1 studies. Graphical Abstract: This review assesses whether the introduction of pressurized intraperitoneal aerosol chemotherapy has followed the IDEAL (Innovation, Development, Evaluation, Assessment, Long-term use) framework, and whether the problems with surgical innovation have been addressed. Pipac and review